Search This Blog

Tuesday, January 12, 2021

SVB Leerink Adjusts Karyopharm Therapeutics' Price Target to $25 from $29

 Keeps Outperform rating

https://www.marketscreener.com/quote/stock/KARYOPHARM-THERAPEUTICS-I-14825950/news/Karyopharm-Therapeutics-SVB-Leerink-Adjusts-Karyopharm-Therapeutics-Price-Target-to-25-from-29-32179238/

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.